Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 1056634-68-4
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
1056634-68-4 |
Appearance :: |
Pale Brown Solid |
Molecular Formula:: |
C23H22N6O2 |
Molecular Weight:: |
414.46 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
CAS NO:: |
1056634-68-4 |
Appearance :: |
Pale Brown Solid |
Molecular Formula:: |
C23H22N6O2 |
Molecular Weight:: |
414.46 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
Product Description:
Product Name: Momelotinib CAS NO:1056634-68-4
Synonyms:
N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)-amino)pyrimidin-4-yl)benzamide;
N-(Cyanomethyl)-4-(2-{[4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)benzamide;
Benzamide, N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-;
Momelotinib;
CYT387;
Chemical & Physical Properties:
Appearance : Pale brown solid.
Assay : ≥98.0%
CYT387 is an inhibitor of Janus kinases JAK1 and JAK2, acting as an ATP competitor with IC50 values of 11 and 18 nM, respectively. The inhibitor is significantly less active towards other kinases, including JAK3 (IC50 = 0.16 μM).
As of 2011, CYT387 is being developed as a drug for myelofibrosis and currently undergoes Phase I/II clinical trials. Additional potential treatment indications for CYT387 include other myeloproliferative neoplasms, cancer (solid and liquid tumors) and inflammatory conditions.
The drug was originally discovered by Australian drug discovery company Cytopia, then developed by YM BioSciences Inc. (since acquired by Gilead Sciences as of 2013).
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
